Mometasone nasal spray 50 mcg/dose 10g

Mometasone Composition:

active ingredient: mometasone furoate; 1 measured dose (0.1 ml) contains mometasone furoate monohydrate (in terms of mometasone furoate) 50 mcg; excipients: microcrystalline cellulose and sodium carmellose, glycerin, benzalkonium chloride, polysorbate 80, citric acid monohydrate, sodium citrate dihydrate, water for injection.

Pharmacotherapeutic group:

Decongestants and other drugs for topical use in diseases of the nasal cavity. Corticosteroids. ATX code R01A D09.

Indications:

Treatment of seasonal or perennial allergic rhinitis in adults and children over 3 years of age. prophylactic treatment of moderate to severe allergic rhinitis is recommended to start 4 weeks before the expected start of the pollination season. treatment of nasal polyps and related symptoms, including nasal congestion and loss of smell, in patients 18 years of age or older.

Shelf life: 2 years. From the moment of the first use – 8 weeks.

Produced in Czech